Biotechnology, Manufacturing, Regulatory · medium ·

US-made biomanufacturing inputs could draw biopharma procurement spending as lawmakers press for supply security

US legislative bodies are increasingly focusing on critical biomanufacturing input assessment, signalling a strategic push to enhance supply chain security and domestic capabilities within a major operator sector. This legislative activity, combined with growing scrutiny on sustainable practices, will drive demand for onshoring and diversification of critical material supply chains.

Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.

Related opportunities